EE473 Cost-Effectiveness of Long-Acting Cabotegravir Plus Long-Acting Rilpivirine for the Treatment of HIV-1 in Taiwan
Jun 1, 2023, 00:00 AM
10.1016/j.jval.2023.03.774
https://www.valueinhealthjournal.com/article/S1098-3015(23)00874-4/fulltext
Section Title :
Section Order :
10243
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00874-4&doi=10.1016/j.jval.2023.03.774